EX-10.16 8 dex1016.htm JOINT DEVELOPMENT AGREEMENT CONFIDENTIAL TREATMENT REQUESTED. CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND, WHERE APPLICABLE, HAVE BEEN MARKED WITH AN ASTERISK TO...Joint Development Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020This Joint Development Agreement (“JDA”) is between Solazyme, Inc., a Delaware corporation (hereinafter referred to as “Solazyme”), having a principal place of business at 225 Gateway Boulevard, South San Francisco, California 94080, and The Dow Chemical Company, a Delaware corporation (hereinafter referred to as “Dow”), having an office at 2301 N. Brazosport Blvd., Building B-1211, Freeport, Texas 77541-3257. Certain terms used in this JDA are defined in Article 11.
JOINT DEVELOPMENT AGREEMENTJoint Development Agreement • April 1st, 2011 • Solazyme Inc • Industrial organic chemicals
Contract Type FiledApril 1st, 2011 Company IndustryThis Joint Development Agreement (“JDA”) is between Solazyme, Inc., a Delaware corporation (hereinafter referred to as “Solazyme”), having a principal place of business at 225 Gateway Boulevard, South San Francisco, California 94080, and The Dow Chemical Company, a Delaware corporation (hereinafter referred to as “Dow”), having an office at 2301 N. Brazosport Blvd., Building B-1211, Freeport, Texas 77541-3257. Certain terms used in this JDA are defined in Article 11.